Celgene AMPATH Oncology Partnership

" Developing a Center of Excellence for Cancer Care in Africa"

Since 2011, Celgene has worked with the Academic Model Providing Access to Healthcare (AMPATH) to support development of the AMPATH Oncology Institute (AOI) as a Center of Excellence in cancer care in the region and to increase access to oncology diagnosis and treatment services for low-income populations in Kenya. AMPATH is  Moi University,  Moi Teaching and Referral Hospital and a  consortium  of North American academic health centers led by Indiana University working in partnership with the Government of Kenya. AMPATH works to deliver health services, conduct health research, and develop leaders in healthcare for both Africa and North America.

The Celgene partnership with AMPATH supports the institution’s tripartite academic missions by developing a sustainable and comprehensive academic clinical cancer care program serving the 20 million citizens of western Kenya. Celgene support to the AMPATH Oncology Institute has also enabled the creation of a successful multiple myeloma (MM) program, the first and only in Kenya. AMPATH has expanded the MM program to 16 outreach sites associated with AMPATH-Oncology and other sites in Western Kenya where it has a hematology or oncology presence.  AOI is now working closely with NCI Kenya to help develop MM protocols of care in the country.